Results 111 to 120 of about 536 (130)

Relationships Between Serum Asunaprevir Concentration and Alanine Aminotransferase Elevation During Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection

Journal of Medical Virology, 2016
Norio Akuta, Hitomi Sezaki, Tetsuya Hosaka   +2 more
exaly  

Randomized Comparison of Daclatasvir + Asunaprevir Versus Telaprevir + Peginterferon/Ribavirin in Japanese Hepatitis C Virus Patients

Journal of Gastroenterology and Hepatology (Australia), 2016
Takayoshi Ito, Yoshito Itoh, Yoshiyasu Karino   +2 more
exaly  

Characterization of ADME Properties of [14C]Asunaprevir (BMS-650032) in Humans

Xenobiotica, 2016
John A Easter, Hao Jiang, Ramaswamy A Iyer   +2 more
exaly  

Population Pharmacokinetic Analysis for Daclatasvir and Asunaprevir in Japanese Subjects With Chronic Hepatitis C Virus Infection

Journal of Clinical Pharmacology, 2018
Tushar Garimella, Takayo Ueno, Hiroki Ishikawa   +2 more
exaly  

Multiplexed LC-MS/MS Method for the Simultaneous Quantitation of Three Novel Hepatitis C Antivirals, Daclatasvir, Asunaprevir, and Beclabuvir in Human Plasma

Journal of Pharmaceutical and Biomedical Analysis, 2015
Hamza Kandoussi, John D Ryan, Mark Arnold   +2 more
exaly  

Asunaprevir: An HCV Protease Inhibitor With Preferential Liver Distribution

Clinical Pharmacology in Drug Development, 2017
Tushar Garimella, Timothy Eley, Wenying Li   +2 more
exaly  

Real-World Efficacy and Safety of Daclatasvir and Asunaprevir Therapy for Hepatitis C Virus-Infected Cirrhosis Patients

Journal of Gastroenterology and Hepatology (Australia), 2017
Masataka Tsuge, Michio Imamura, Tomokazu Kawaoka   +2 more
exaly  

Asunaprevir (BMS-650032) for the Treatment of Hepatitis C Virus

Expert Review of Anti-Infective Therapy, 2015
Yoshihiro Sakamoto, Yasuhiko Sugawara, Nobuhisa Akamatsu   +2 more
exaly  

A Highly Sensitive and Selective LC–MS/MS Method to Quantify Asunaprevir, an HCV NS3 Protease Inhibitor, in Human Plasma in Support of Pharmacokinetic Studies

Journal of Pharmaceutical and Biomedical Analysis, 2016
Hamza Kandoussi, Naiyu Zheng, Mark Arnold   +2 more
exaly  

Population Pharmacokinetic Analysis of Daclatasvir, Asunaprevir, and Beclabuvir Combination in HCV-Infected Subjects

Clinical Pharmacology in Drug Development, 2019
Tushar Garimella, Hanbin Li, Takayo Ueno
exaly